Pnc Financial Services Group, Inc. Iovance Biotherapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

$162 Billion
Q3 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 51,056 shares of IOVA stock, worth $126,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,056

Previous 222 22898.2%

Holding current value

$126,108

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$1.7 - $3.97 $86,417 - $201,810	50,834 Added 22898.2%	51,056 $110,000
Q2 2025 Aug 08, 2025	SELL	$1.66 - $3.61 $2,566 - $5,581	-1,546 Reduced 87.44%	222 $0
Q1 2025 May 09, 2025	BUY	$3.33 - $7.79 $3,859 - $9,028	1,159 Added 190.31%	1,768 $5,000
Q4 2024 Feb 07, 2025	SELL	$7.17 - $12.28 $2,308 - $3,954	-322 Reduced 34.59%	609 $4,000
Q3 2024 Nov 08, 2024	SELL	$7.28 - $11.9 $15,266 - $24,954	-2,097 Reduced 69.25%	931 $8,000

Q2 2024 Aug 09, 2024	BUY	$7.78 - $14.19 $13,101 - $23,895	1,684 Added 125.3%	3,028 $24,000
Q1 2024 May 10, 2024	BUY	$7.59 - $17.47 $3,286 - $7,564	433 Added 47.53%	1,344 $19,000
Q4 2023 Feb 09, 2024	BUY	$3.3 - $8.89 $1,890 - $5,093	573 Added 169.53%	911 $7,000
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $763 - $1,511	172 Added 103.61%	338 $1,000
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $652 - $969	118 Added 245.83%	166 $1,000
Q4 2022 Feb 10, 2023	SELL	$5.62 - $10.0 $269 - $480	-48 Reduced 50.0%	48 $0
Q3 2022 Nov 10, 2022	SELL	$9.53 - $13.11 $1,029 - $1,415	-108 Reduced 52.94%	96 $0
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $319 - $916	-50 Reduced 19.69%	204 $2,000
Q1 2022 May 12, 2022	SELL	$12.38 - $19.1 $24,797 - $38,257	-2,003 Reduced 88.75%	254 $4,000
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $40,117 - $66,975	-2,424 Reduced 51.78%	2,257 $43,000
Q3 2021 Nov 05, 2021	BUY	$20.35 - $26.63 $81,237 - $106,306	3,992 Added 579.39%	4,681 $115,000
Q2 2021 Aug 06, 2021	BUY	$16.33 - $33.07 $5,013 - $10,152	307 Added 80.37%	689 $17,000
Q1 2021 May 07, 2021	BUY	$28.67 - $52.59 $1,261 - $2,313	44 Added 13.02%	382 $12,000
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $420 - $753	15 Added 4.64%	338 $15,000
Q3 2020 Nov 06, 2020	SELL	$27.75 - $36.3 $971 - $1,270	-35 Reduced 9.78%	323 $10,000
Q2 2020 Aug 07, 2020	BUY	$27.21 - $41.0 $6,693 - $10,086	246 Added 219.64%	358 $9,000
Q1 2020 May 08, 2020	BUY	$19.54 - $38.85 $234 - $466	12 Added 12.0%	112 $3,000
Q4 2018 Feb 08, 2019	SELL	$7.51 - $11.93 $7,510 - $11,930	-1,000 Reduced 90.91%	100 $0
Q3 2018 Nov 09, 2018	BUY	$11.25 - $17.7 $1,125 - $1,770	100 Added 10.0%	1,100 $0
Q3 2017 Nov 13, 2017	BUY	$4.45 - $8.55 $4,450 - $8,550	1,000	1,000 $0

Others Institutions Holding IOVA

# of Institutions

292

Shares Held

219M

Call Options Held

2.41M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $390M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Iovance Biotherapeutics, Inc. Transaction History